The Roadmap to Real-Time Data Sharing in Clinical Trials

07/14/2021 By Andrea

Article authored and contributed to PharmaLeaders by Marc Leighton, VP of Product for Florence Healthcare With the rise of decentralized technology across the clinical trial industry, real-time data sharing has become critical. If research sites, local physicians, trial participants, CROs, and sponsors can’t instantly share data with one another, remote or hybrid clinical trials will […]

How Training Simulations Will Help Pharma Sales Teams in the Post-Pandemic Market

06/09/2021 By Andrea

Article contributed to PharmaLeaders and authored by: Jeremy Lovelace, founder and director of HFX Training. Across all industries, sales teams face an uncertain future, and pharma is no different. Many key sales practices, such as healthcare provider meetings and terrority-focused engagement have been replaced by the unfamiliar environment of zoom calls, emails and remote […]

Three US drug distributors agree to pay $1.18bn to settle opioid case in New York

07/23/2021

McKesson Corporation, Cardinal Health and Amerisource Bergen Drug, the three largest US drug distributors, have agreed to pay up to $1.18bn to settle the ongoing opioid-related case with The post Three US drug distributors agree to pay $1.18bn to settle opioid case in New York appeared first on … [Read More...]

Biovac partners with Pfizer and BioNTech to manufacture Covid-19 vaccine

07/23/2021

Pfizer and BioNTech have signed a letter of intent with The Biovac Institute, the South African biopharmaceutical company, to jointly manufacture and distribute their Covid-19 Vaccine in the The post Biovac partners with Pfizer and BioNTech to manufacture Covid-19 vaccine appeared first on … [Read More...]

AstraZeneca completes acquisition of biopharmaceutical firm Alexion

07/23/2021

AstraZeneca has completed the acquisition of biopharmaceutical company Alexion Pharmaceuticals in a deal valued at $39bn. The latest move comes after the receipt of clearance from the UK The post AstraZeneca completes acquisition of biopharmaceutical firm Alexion appeared first on Pharmaceutical … [Read More...]

Pfizer and Arvinas to jointly develop and commercialise breast cancer drug

07/23/2021

Pfizer and Arvinas have collaborated to co-develop and co-commercialise ARV-471, an investigational oral Protac estrogen receptor protein degrader. The estrogen receptor (ER) is a well-known disease driver in The post Pfizer and Arvinas to jointly develop and commercialise breast cancer drug … [Read More...]

Featured Article

The Roadmap to Real-Time Data Sharing in Clinical Trials

How Training Simulations Will Help Pharma Sales Teams in the Post-Pandemic Market

White Papers

The Future of Professional Medical Education

Engaging Users of Healthcare Provider Communities

Industry News

Three US drug distributors agree to pay $1.18bn to settle opioid case in New York

Biovac partners with Pfizer and BioNTech to manufacture Covid-19 vaccine

AstraZeneca completes acquisition of biopharmaceutical firm Alexion

Pfizer and Arvinas to jointly develop and commercialise breast cancer drug